NewsDialy
Pomerantz LLP, the New York-based law firm, has announced the filing of a class action lawsuit against ADMA Biologics, Inc.
(NASDAQ: ADMA), urging investors who suffered losses on their ADMA positions to contact the firm before an approaching legal deadline.
The alert, issued June 18, 2026, is directed at shareholders who believe their investment in the biologic company resulted in financial harm.
What a Class Action Lawsuit Means for Investors A securities class action is a legal mechanism that allows a group of investors who suffered similar losses to sue a company collectively rather than individually.
Keep reading